4.6 Article

Satisfaction with treatment among patients with psoriasis: a web-based survey study

期刊

BRITISH JOURNAL OF DERMATOLOGY
卷 169, 期 2, 页码 398-405

出版社

WILEY-BLACKWELL
DOI: 10.1111/bjd.12372

关键词

-

资金

  1. Abbott
  2. Department of Dermatology, Academic Medical Center of Amsterdam
  3. Dutch Society of Dermatology and Venereology
  4. Galderma
  5. LEO Pharma
  6. Novartis Pharma
  7. Pfizer
  8. MSD
  9. Teva Netherlands
  10. Waldmann Medical Lighting

向作者/读者索取更多资源

Background Various psoriasis treatments are currently available: topical therapy, photo(chemo)therapy, oral agents and biologics. Little is known about patients' satisfaction with these treatment options. Moreover, the few available studies show methodological shortcomings. Objectives To answer the following questions: firstly, how satisfied are patients with psoriasis with their current treatment and does patients' satisfaction significantly differ between treatment types when controlling for demographic and clinical factors? Secondly, how important are specific domains of satisfaction to patients, and when taking perceived importance into account, which domains merit the most attention in improving quality of care? Methods Members of the two existing Dutch associations for patients with psoriasis were invited to complete a web-based survey, which included a study-specific satisfaction questionnaire. Results A total of 1293 patients completed the survey (response rate 32%). Overall, patients were moderately satisfied with their current treatment. Patients receiving topical treatment were significantly least satisfied; patients receiving biologic treatment were significantly most satisfied. Overall, patients rated treatment effectiveness' as most important, followed by treatment safety' and doctor-patient communication'. Domains with the highest room for improvement' scores were effectiveness of topical therapy, phototherapy and oral agents (but not biologic treatment), convenience of topical treatment and safety of systemic treatments (both oral agents and biologics). Conclusions From the perspective of patients, biologic treatment is promising. To improve further the quality of psoriasis care, the effectiveness and convenience of topical therapies, the safety of systemic therapies, and doctors' communication skills need to be addressed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据